eIg-based bispecific T-cell engagers targeting EGFR: Format matters
ABSTRACTBispecific antibodies are molecules with versatile modes of action and applications for therapy. They are commonly developed as T-cell engagers (TCE), which simultaneously target an antigen expressed by tumor cells and CD3 expressed by T-cells, thereby inducing T-cell-mediated target cell ki...
Saved in:
Main Authors: | Lennart Kühl (Author), Annelie K. Schäfer (Author), Sebastian Kraft (Author), Nadine Aschmoneit (Author), Roland E. Kontermann (Author), Oliver Seifert (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The eIg technology to generate Ig-like bispecific antibodies
by: Lennart Kühl, et al.
Published: (2022) -
A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3
by: Alexander Rau, et al.
Published: (2021) -
Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1
by: Nishant Mohan, et al.
Published: (2022) -
Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers
by: Ammelie Svea Boje, et al.
Published: (2024) -
Manufacturability and functionality assessment of different formats of T-cell engaging bispecific antibodies
by: Han Ping Loh, et al.
Published: (2023)